My watch list  

FDA Fast Track Development Program

The FDA Fast Track Development Program is a designation of the United States Food and Drug Administration that accelerates the approval of investigational new drugs undergoing clinical trials. Such status is often given to agents that show promise in treating serious, life-threatening medical conditions for which no other drug either exists or works as well.


  • FDA website
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "FDA_Fast_Track_Development_Program". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE